Form 4: NeuroMetrix Director Higgins Reports Stock Transactions
SEC Form 4 Filing
Director Thomas T. Higgins reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On April 1, 2025, Director Thomas T. Higgins of NeuroMetrix, Inc. reported transactions involving common stock.
- Higgins acquired 469 shares of common stock upon the vesting of restricted stock units at a price of $4.41 per share.
- 76 shares were withheld for payment of withholding taxes at a price of $4.41 per share.
- Following these transactions, Higgins directly owns 11,840 shares of NeuroMetrix common stock.
- Higgins also directly owns 2,811 derivative securities in the form of restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock vesting and tax withholding, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the normal course of equity compensation for a company director.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects the ongoing equity compensation plan for a director.
Key Dates
| Date | Description |
|---|---|
| November 22, 2023 | Reporting person was granted 5,625 restricted stock units. |
| January 1, 2024 | Vesting of restricted stock units began in equal quarterly installments over three years. |
| April 1, 2025 | Transaction date: vesting of 469 restricted stock units and withholding of 76 shares for taxes. |
| April 3, 2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, NeuroMetrix, Director, Higgins, Stock, Restricted Stock Units, Vesting, Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.